Why the study?
Functional alterations resulting from multiple mutations associated with an overlap arrhythmia syndrome of Early Repolarization Syndrome and Short QT Syndrome required characterization using patient-derived hiPSC-CMs.
Population
One index patient with arrhythmia-mediated syncope carrying six mutations and healthy controls
Comparison
Patient-derived hiPSC-CMs vs healthy control hiPSC-CMs
Design
In vitro electrophysiological and molecular comparative study using hiPSC-CMs
Cellular study uncovers reduced sodium current and shortened action potentials in patient-derived cardiomyocytes, indicating a polygenic cause for overlap arrhythmia syndromes.
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are used for genetic models of cardiac diseases. We report an arrhythmia syndrome consisting of Early Repolarization Syndrome (ERS) and Short QT Syndrome (SQTS). The index patient (MMRL1215) developed arrhythmia-mediated syncope after electrocution and was found to carry six mutations. Functional alterations resulting from these mutations were examined in patient-derived hiPSC-CMs. Electrophysiological recordings were made in hiPSC-CMs from MMRL1215 and healthy controls. ECG analysis of the index patient showed slurring of the QRS complex and QTc = 326 ms. Action potential (AP) recordings from MMRL1215 myocytes showed slower spontaneous activity and AP duration was shorter. Field potential recordings from MMRL1215 hiPSC-CMs lack a “pseudo” QRS complex suggesting reduced inward current(s). Voltage clamp analysis of ICa showed no difference in the magnitude of current. Measurements of INa reveal a 60% reduction in INa density in MMRL1215 hiPSC-CMs. Steady inactivation and recovery of INa was unaffected. mRNA analysis revealed ANK2 and SCN5A are significantly reduced in hiPSC-CM derived from MMRL1215, consistent with electrophysiological recordings. The polygenic cause of ERS/SQTS phenotype is likely due to a loss of INa due to a mutation in PKP2 coupled with and a gain of function in IK,ATP due to a mutation in ABCC9.
No takes yet. Share an insight, caveat, or question.
Treat et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: